NCI COVID-19 in Cancer Patients, NCCAPS Study

Brief summary (registry, in English)

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19.

What you commit to

• Study type: Observational
• Participants enrolled: 1877
• From 5 Jun 2020 to the primary completion date, 20 Mar 2024
• 932 sites in 3 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (932)

Sites in registry order. Pick your city on the disease page to sort them by distance.